InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Crinetics Pharmaceuticals, Inc.

CRNX Clue Score58
United States Fiscal year ends December CIK 0001658247
$84.95 +0.00% Close, 1 Sep 2026
Alert on the numbers Alert on insider trades
Price $84.95 +254.25% Close, 1 Sep 2026

Closing prices at the end of each trading day, from 18 Jul 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.6Operating income−6.0Net income−6.0Fiscal year 2017Revenue2.0 +247.2%Operating income−9.1Net income−9.2Fiscal year 2018Revenue2.4 +18.7%Operating income−28.7Net income−27.1Fiscal year 2019Revenue1.2 −50.9%Operating income−53.8Net income−50.4Fiscal year 2020Revenue0.1 −94.0%Operating income−75.0Net income−73.8EPS, diluted−2.42Fiscal year 2021Revenue0.0 −100.0%Operating income−107.7Net income−107.6EPS, diluted−2.80Fiscal year 2022Revenue0.0Operating income−167.9Net income−163.9EPS, diluted−3.15Fiscal year 2023Revenue4.0Operating income−222.6Net income−214.5EPS, diluted−3.69Fiscal year 2024Revenue1.0 −74.1%Operating income−338.9Net income−298.4EPS, diluted−3.69Fiscal year 2025Revenue7.7 +640.7%Operating income−516.8Net income−465.3EPS, diluted−4.95
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.6 2.0 2.4 1.2 0.1 0.0 0.0 4.0 1.0 7.7
Growth +247.2% +18.7% −50.9% −94.0% −100.0% −74.1% +640.7%
Operating income −6.0 −9.1 −28.7 −53.8 −75.0 −107.7 −167.9 −222.6 −338.9 −516.8
Net income −6.0 −9.2 −27.1 −50.4 −73.8 −107.6 −163.9 −214.5 −298.4 −465.3
Growth
EPS, diluted n/a n/a n/a n/a −2.42 −2.80 −3.15 −3.69 −3.69 −4.95
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−1,026.1%Net margin−1,021.9%Free cash flow margin−960.6%Fiscal year 2017Operating margin−446.3%Net margin−447.8%Free cash flow margin−478.4%Fiscal year 2018Operating margin−1,182.5%Net margin−1,116.8%Free cash flow margin−845.1%Fiscal year 2019Operating margin−4,512.3%Net margin−4,226.5%Free cash flow margin−3,929.0%Fiscal year 2020Operating margin−105,567.6%Net margin−103,960.6%Free cash flow margin−87,623.9%Fiscal year 2021Fiscal year 2022Fiscal year 2023Operating margin−5,547.2%Net margin−5,345.9%Free cash flow margin−4,318.1%Fiscal year 2024Operating margin−32,613.5%Net margin−28,720.7%Free cash flow margin−22,525.3%Fiscal year 2025Operating margin−6,714.8%Net margin−6,046.2%Free cash flow margin−4,985.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −1,026.1% −446.3% −1,182.5% −4,512.3% −105,567.6% n/a n/a −5,547.2% −32,613.5% −6,714.8%
Net margin −1,021.9% −447.8% −1,116.8% −4,226.5% −103,960.6% n/a n/a −5,345.9% −28,720.7% −6,046.2%
Free cash flow margin −960.6% −478.4% −845.1% −3,929.0% −87,623.9% n/a n/a −4,318.1% −22,525.3% −4,985.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−5.5Capital expenditure−0.2Free cash flow−5.7Fiscal year 2017Operating cash flow−9.5Capital expenditure−0.3Free cash flow−9.8Fiscal year 2018Operating cash flow−19.5Capital expenditure−1.1Free cash flow−20.5Fiscal year 2019Operating cash flow−46.4Capital expenditure−0.5Free cash flow−46.9Fiscal year 2020Operating cash flow−62.0Capital expenditure−0.2Free cash flow−62.2Fiscal year 2021Operating cash flow−88.6Capital expenditure−0.4Free cash flow−89.0Fiscal year 2022Operating cash flow−115.2Capital expenditure−1.7Free cash flow−116.9Fiscal year 2023Operating cash flow−168.6Capital expenditure−4.7Free cash flow−173.3Fiscal year 2024Operating cash flow−230.2Capital expenditure−3.8Free cash flow−234.0Fiscal year 2025Operating cash flow−377.9Capital expenditure−5.8Free cash flow−383.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −5.5 −9.5 −19.5 −46.4 −62.0 −88.6 −115.2 −168.6 −230.2 −377.9
Capital expenditure −0.2 −0.3 −1.1 −0.5 −0.2 −0.4 −1.7 −4.7 −3.8 −5.8
Free cash flow −5.7 −9.8 −20.5 −46.9 −62.2 −89.0 −116.9 −173.3 −234.0 −383.7
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash12.2Shareholders’ equity−6.2Fiscal year 2017Cash14.2Shareholders’ equity−15.0Fiscal year 2018Cash45.0Shareholders’ equity160.2Fiscal year 2019Cash40.3Shareholders’ equity117.1Fiscal year 2020Cash93.1Shareholders’ equity168.9Fiscal year 2021Cash200.7Shareholders’ equity331.9Fiscal year 2022Cash32.7Shareholders’ equity316.3Fiscal year 2023Cash54.9Shareholders’ equity539.1Fiscal year 2024Cash264.5Shareholders’ equity1,324.8Fiscal year 2025Cash101.5Shareholders’ equity992.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 12.2 14.2 45.0 40.3 93.1 200.7 32.7 54.9 264.5 101.5
Shareholders’ equity −6.2 −15.0 160.2 117.1 168.9 331.9 316.3 539.1 1,324.8 992.1

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
0.6 2.0 2.4 1.2 0.1 0.0 0.0 4.0 1.0 7.7
Growth +247.2% +18.7% −50.9% −94.0% −100.0% −74.1% +640.7%
n/a n/a n/a n/a n/a n/a n/a 0.0 0.0 1.1
5.1 9.2 24.5 41.5 57.0 84.3 130.2 168.5 240.2 332.1
1.5 1.9 6.7 13.5 18.0 24.5 42.4 58.1 99.7 191.3
−6.0 −9.1 −28.7 −53.8 −75.0 −107.7 −167.9 −222.6 −338.9 −516.8
Growth
−6.0 −9.2 −27.1 −50.4 −73.8 −107.6 −163.9 −214.5 −298.4 −465.1
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2
−6.0 −9.2 −27.1 −50.4 −73.8 −107.6 −163.9 −214.5 −298.4 −465.3
Growth
Per share
n/a n/a n/a n/a −2.42 −2.80 −3.15 −3.69 −3.69 −4.95
n/a n/a n/a n/a −2.42 −2.80 −3.15 −3.69 −3.69 −4.95
Growth
n/a n/a n/a n/a 30.4 38.4 52.0 58.1 80.8 94.1
n/a n/a n/a n/a 30.4 38.4 52.0 58.1 80.8 94.1
Growth +26.2% +35.2% +11.7% +39.1% +16.4%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 155.3% a year over five years.
  • The diluted share count rose 208.9% in five years, which is dilution.
  • Operating margin is up 98,852.8 points on five years ago, at -6,714.8%.
  • A net loss in 10 of 10 years on file.